Manuela Buzoianu

A Dynamic Supply-Demand Model for Electricity Prices

Anthony Brockwell, Manuela Buzoianu, Duane J. Seppi, 2005 .

A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin αvβ3, ± dacarbazine in patients with stage IV metastatic melanoma

J. Sosman, J. Kirkwood, P. Hersey, 2010, Cancer.

HLA‐Specific Antibodies are Risk Factors for Lymphocytic Bronchiolitis and Chronic Lung Allograft Dysfunction

B. Griffith, T. Corcoran, S. Yousem, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

A Novel Anti-CD22 Immunotoxin, Moxetumomab Pasudotox: Phase I Study in Pediatric Acute Lymphoblastic Leukemia (ALL)

C. Pui, I. Pastan, L. Silverman, 2011 .

Circulating Tumor Cells: Application as a Biomarker for Molecular Characterization and Predictor of Survival in an All-Comer Solid Tumor Phase I Clinical Study

R. Lechleider, R. Sikorski, Jianliang Zhang, 2013, PloS one.

Sex-specific Long-term Outcomes of Watchman Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation

R. Zusterzeel, A. Farb, M. Moscucci, 2023, Journal of the Society for Cardiovascular Angiography & Interventions.

Pharmacodynamic (Phase 0) Study Using Etaracizumab in Advanced Melanoma

Manuela Buzoianu, Charalambos Athanassiou, Drazen M Jukic, 2010, Journal of immunotherapy.

Adjusting for verification bias in diagnostic test evaluation: A Bayesian approach

Manuela Buzoianu, Joseph B Kadane, J. Kadane, 2008, Statistics in medicine.

Optimal Bayesian Design for Patient Selection in a Clinical Study

Manuela Buzoianu, Joseph B Kadane, J. Kadane, 2009, Biometrics.

Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumors

E. Kohn, P. LoRusso, R. Lechleider, 2012, Investigational New Drugs.

A Novel Anti-CD22 Immunotoxin, Moxetumomab Pasudotox (HA22, CAT-8015): Activity in Pediatric Patients with Relapsed Acute Lymphoblastic Leukemia (ALL) After Allogeneic Hematopoietic Stem Cell Transplantation (SCT)

I. Pastan, L. Silverman, J. Whitlock, 2012 .

A Phase 1 Study of Moxetumomab Pasudotox, An Anti-CD22 Recombinant Immunotoxin, In Relapsed/Refractory Hairy Cell Leukemia (HCL): Updated Results

I. Pastan, R. Lechleider, M. Tallman, 2010 .

Some Thoughts on the Use of Predictive Probability in Clinical Trials

L. Dong, Heng Li, Xuefeng Li, 2023, Therapeutic Innovation & Regulatory Science.